Navigation Links
NVISION Eye Centers Sign National Account Agreement for Imprimis Pharmaceuticals' Ophthalmic Compounded Formulations
Date:11/24/2015

San Diego-based Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a national leader in the development, production and dispensing of novel compounded pharmaceuticals.  The company's business primarily consists of four therapeutic segments including ophthalmology, urology, sinus and integrative medicine.  Imprimis dispenses compounded pharmaceuticals in all 50 states from four facilities located in California, Texas, New Jersey and Pennsylvania.  For more information about Imprimis, please visit the corporate website at www.ImprimisPharma.com

All Imprimis compounded formulations may only be prescribed pursuant to a physician prescription for an individually identified patient consistent with federal and state laws governing compounded drug formulations.

SAFE HARBOR

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward-looking statements." Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include risks and uncertainties related to Imprimis' ability to make commercially available its compounded formulations and technologies in a timely manner, at price points that are attractive to physicians and patients or at all; physician interest in prescribing and patient interest in using its formulations; risks related to its compounding pharmacy operations; its ability to enter into strategic alliances, including arrangements with pharmacies, physicians and healthcare organizations for the development and distribution of its formulations; its ability to obtain intellectual property protection for its assets; its ability to accurately estimate its expenses and cash burn, and raise additional funds when necessary; risks related to research and development activities; the projected size of the potential market for its technologies and formulations; unexpected new data, safety and technical issues; regulatory and market developments impacting compounding pharmacies, outsourcing facilities and the pharmaceutical industry; competition; and market conditions. These and additional risks and uncertainties are more fully described in Imprimis' filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Such documents may be read free of charge on the SEC's web site at www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Imprimis undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

Imprimis Pharmaceuticals Contacts

Investor Contact
Bonnie Ortega
bortega@imprimispharma.com
858.704.4587                                                                                                                                         

Media Contact
Deb Holliday
deb@pascalecommunications.com
412.877.4519

NVISION Eye Centers Contact
Dimas Garcia
dimas.garcia@nvisioncenters.com
949.274.4652 x11024  

Logo - http://photos.prnewswire.com/prnh/20150108/167712LOGO


'/>"/>
SOURCE Imprimis Pharmaceuticals, Inc.; NVISION Eye Centers, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare
2. Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
3. Mio Global Receives Envisioneerings Innovation and Design Award at CES
4. BioDrain Breaks into National Network of Ambulatory Surgical Centers and Expands Installations of its STREAMWAY System throughout the U.S.
5. U.S. News & World Report Honors 7 SynCardia Certified Centers Among "Best Childrens Hospitals" for Cardiology and Heart Surgery
6. Queen Emma Land Company and Taubman Centers Announce Saks Fifth Avenue to Anchor the Revitalized International Market Place
7. Sharp Rees-Stealy Medical Centers Launches Asthmapolis Mobile Asthma Management Program
8. The Centers For Medicare & Medicaid Services (CMS) Draft Decision Could Limit Patient Access To New Technology That May Help In Diagnosing Dementia
9. Large National Network of Ambulatory Surgical Centers Doubles Order of STREAMWAY Systems
10. Piramal Imaging Provides Comments in Response to the Centers for Medicare and Medicaid Services (CMS) Proposed Coverage Decision for Beta-Amyloid Positron Emission Tomography (PET)
11. BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... October 08, 2019 , ... Clements Ferry Dentistry has rebranded ... team are thrilled to create an atmosphere that is even more inviting and ... The mission of Sedation Dentistry of Charleston is to provide trusted, comprehensive dental ...
(Date:10/8/2019)... Vicksburg, MS (PRWEB) , ... October 08, 2019 ... ... Dentistry, recently participated in an advanced dental implant seminar to enhance his skill ... around the country, The Implant Dentistry Continuum™ is a four-part series of classes ...
(Date:10/8/2019)... ... October 08, 2019 , ... For many Americans, dental insurance ... procedures is paid out of pocket. Yearly insurance payouts are generally capped at around ... including 46 million people who are 65 or older. (Standard Medicare does not cover ...
Breaking Medicine Technology:
(Date:10/17/2019)... ... October 17, 2019 , ... A clinical article reviewing the long-term performance of ... Award at Plastic Surgery - The Meeting 2019 in San Diego last month. The ... authored by Larry S. Nichter, M.D., Robert A. Hardesty, M.D., and Gregg M. Anigian, ...
(Date:10/15/2019)... ... ... In 2019, Unitek opened its doors to various nursing students from Brightwood ... who started in July were only entering their second term when the school closed ... start over. Then the leadership team at Unitek honored their commitment to the community ...
(Date:10/11/2019)... ... October 11, 2019 , ... A Topping Out event was hosted today ... general contractors Adolfson & Peterson Construction. The event celebrated reaching the final height of ... in Dallas. The first of its kind in Texas, STA’s facility will be home ...
(Date:10/8/2019)... ... October 08, 2019 , ... Safe Harvest soups ... Meyer, King Sooper, Fry’s, Roundy’s, Smiths and Dillons. , Safe Harvest reinvented classic ... , “Ingredient purity and fresh taste is paramount for us,” says Bryan Boches, ...
(Date:10/8/2019)... ... October 08, 2019 , ... Cognosante ... the Department of Veterans Affairs Community Care Referrals and Authorizations program. The new ... VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by community care ...
Breaking Medicine News(10 mins):